ICICIGI CMP 1938. TARGET 1987. SL 1920.

Jun 11, 2025 - 20:43
 0  0
ICICIGI CMP 1938. TARGET 1987. SL 1920.

ICICIGI CMP 1938. TARGET 1987. SL 1920.

The company’s Gross Direct Premium Income (GDPI) grew 8.3% in FY2025, outpacing the broader industry (+6.2%). Earlier in H1 FY25 (Q2), GDPI surged 10.4%, compared to a modest 2% industry growth—highlighting robust demand across product segments. Analysts highlighted a 24% EPS beat for Q3 and projects revenue growth of ~12% annually over the next 3 years—surpassing the industry average (~8%). Post-Q4 results, analysts reaffirmed their price target around 2,140 per share, showing continued confidence despite cautious near-term outlook.

The strength of the company y is its Solvency ratio remains robust—2.36x in Q3 FY25, well above regulatory minimums. The board has recommended a final dividend of 7 per share for FY2025, rewarding shareholders for another good year.

Company Profile :

The company is a Joint venture between ICICI Bank (about 64%) and Fairfax Financial (about 36%)—now fully consolidated under ICICI Bank since Feb 2024. Company offers Comprehensive range of non-life insurance products—motor, health, travel (including student & senior plans), home, crop, fire, marine, engineering, liability, cyber, weather, aerospace and more. Multiple avenues—direct sales, individual agents (~113,000), corporate agents, brokers, bancassurance with ICICI Bank, YES Bank, Karur Vysya, and online platforms. The company stands as a first major Indian general insurer to migrate core systems to the cloud; won acclaim for AI-powered claim approvals and instant motor damage assessments.

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
ASJ_Stockmarketclasses I’m Prasad Bhave, a Senior Research Analyst with over 15 years of experience in market intelligence, data-driven strategy, and trend forecasting. I specialize in translating complex data into actionable insights that support business growth and decision-making. My work spans across sectors including Finance / FMCG / Technology / Healthcare, where I’ve led high-impact research projects, competitor analysis, and strategic reports for C-level stakeholders. I’m passionate about combining deep research with practical outcomes, and thrive in environments that demand both analytical rigor and creative thinking. Whether it's uncovering hidden market opportunities or refining business strategies, I aim to deliver clarity and results through data.